DynaMed
For the primary audience consists of clinicians and medical professionals requiring rapid access to evidence-based clinical information.
Overview · Full Intel report in progress
DynaMed is an established medical app that is completely free. With a 4.8/5 rating from 5.5K reviews, it shows polarized user reception.
What is DynaMed?
Current Momentum
v5.5 · 3mo ago
SteadyLast updated 118d ago. 5 versions tracked.
Competition
Rivals identification in progress
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
What makes this app unique?
What Are The Key Features?
Provides clinical guidance derived from the rigorous, daily review of medical literature by staff physicians and specialists.
Enables seamless transition between desktop and mobile interfaces to support clinicians working on-the-go.
Offers objective synthesis and analysis of medical data to facilitate efficient patient care.
How much does it cost?
Who Built It?
EBSCO Publishing
Providing clinicians and researchers with evidence-based medical and scholarly resources. Facilitating professional workflows through cross-platform content synchronization.
Portfolio
6
Apps
What other apps does EBSCO Publishing make?
Explore the full EBSCO Publishing report
Portfolio breakdown, audience, momentum, and every app published by EBSCO Publishing.
Analysis in progress, available soon
What do users think recently?
Analysis in progress, available soon
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
Analysis in progress, available soon
What is the competitive landscape for DynaMed?
How's The Medical Market?
How does it evolve in the Medical market?
Rank progression
27 active rankings tracked — 30-day window
Strategic analysis coming soon
SWOT, key takeaways & outlook
The outtake for DynaMed
Key Takeaways
DynaMed functions as a mobile-accessible clinical reference tool designed to provide clinicians with timely, evidence-based medical insights.
Where Is It Heading?
Trend analysis
Available very soon